Yes thrasher suggest you listen to the webinar where Cheryl stated that big pharma are not interested in our three dep drugs at the Ph2 completion level. They are more interested in more current and emerging treatments. The inference was that if Ph3 trials were completed then potentially they would take a look.
If our mob hadn’t stuffed around for literally years with these trials it may have resulted in some serious deals.
This country centric or region centric approach they are mentioning seems very strange to me particularly in relation to approvals. I think we deserve a lot more
detail about this approach as it all sounds wishy washy to me
- Forums
- ASX - By Stock
- SPL
- Ann: Positive final DEP irinotecan Phase 2 clinical trial results
Ann: Positive final DEP irinotecan Phase 2 clinical trial results, page-12
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
10.5¢ |
Change
0.007(7.14%) |
Mkt cap ! $43.29M |
Open | High | Low | Value | Volume |
9.5¢ | 10.5¢ | 9.5¢ | $8.154K | 83.09K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5102 | 9.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 124847 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5102 | 0.098 |
1 | 6185 | 0.097 |
1 | 20000 | 0.096 |
2 | 528090 | 0.095 |
3 | 40638 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 124847 | 3 |
0.110 | 114609 | 7 |
0.115 | 77331 | 6 |
0.120 | 89055 | 5 |
0.125 | 281784 | 3 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
HCH
Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
SPL (ASX) Chart |